Advances in ADT: A Guide for Urologists and APPs CME Available: https://auau.auanet.org/node/37866 At the conclusion of this activity, participants will be able to: 1. Identify and treat a patient with new diagnosed M1 prostate cancer with ADT plus be able to offer additional therapies that extend survival. 2. Analyze the risks and benefits of treatment for M1 HSPC, MO CRPC, and M1 CRPC. 3. Differentiate the clinical significance of GnRH agonists vs. GnRH antagonists and newer treatments that complement these options. 4. Identify opportunities for shared care and team-based approaches of patients with advanced prostate cancer. 5. Facilitate discussions with patients and caregivers regarding ADT and advanced prostate cancer treatment. ACKNOWLEDGEMENTS Independent educational grant support provided by: Myovant Sciences LTD Pfizer Inc.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 11PM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 10PM EST
08 Dec 2025
NPR News Now
Meidas Health: AAP President Strongly Pushes Back on Hepatitis B Vaccine Changes
08 Dec 2025
The MeidasTouch Podcast
Democrat Bobby Cole Discusses Race for Texas Governor
07 Dec 2025
The MeidasTouch Podcast
Fox News Crashes Out on Air Over Trump’s Rapid Fall
07 Dec 2025
The MeidasTouch Podcast